by The global molecular diagnostics market size accounted for US$ 12.7 Bn in 2021 and is projected to reach around USD 48.9 Bn by 2030, growing at a CAGR of 16.16% from 2022 to 2030.
Molecular Diagnostics Market Key Takeaways:
- By product type, the reagent segment has held 61% market share in 2021.
- By application, the infectious disease segment has reached 47% market share in 2021.
- By end user, the hospitals segment has accounted 62% market share in 2021.
- By region, North America market growth is registering at a CAGR of 9.3% during the forecast period.
- Europe market has accounted highest revenue share of over 29.6% in 2021
Report Summary
The global molecular diagnostics market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the molecular diagnostics market across the globe.
A comprehensive estimate on the molecular diagnostics market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of molecular diagnostics during the forecast period. Price point comparison by region with global average price is also considered in the study.
Molecular Diagnostics Market Scope
| Report Coverage | Details |
| Market Size in 2022 | USD 14.75 Billion |
| Market Size by 2030 | USD 48.9 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 16.16% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Test Location, Technology, Application, End User, and Geography |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized molecular diagnostics market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Medical Textiles Market Size Analysis 2022 To 2030
Molecular Diagnostics Market Players
The report includes the profiles of key molecular diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Major companies operating in this area are Siemens Healthineers AG (Germany), Quidel Corporation (US), F. Hoffmann-La Roche Ltd. (Switzerland), Hologic, Inc. (US), Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Illumina, Inc. (US), Becton, Dickinson and Company (US), Grifols, S.A. (Spain), PerkinElmer, Inc. (US), Abbott Laboratories (US), bioMérieux SA (France), QIAGEN N.V. (Netherlands), Myriad Genetics, Inc. (US), Agilent Technologies, Inc. (US), geneOmbio Technologies Pvt. Ltd. (India)
Market Segmentation
By Product
- Instruments
- Reagents
- Services & Software
By Test Location
- Central laboratories
- Point of care
- Over the counter or self-test kits
By Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- DNA Sequencing & Next- generation Sequencing (NGS)
- In Situ Hybridization (ISH)
- DNA Microarrays
- Others
By Application
- Infectious diseases
- COVID-19
- Hepatitis
- HIV
- CT/NG
- HAI
- HPV
- Tuberculosis
- Influenza
- Other Infectious Diseases
- Oncology
- Breast Cancer
- Colorectal Cancer
- Lung Cancer
- Prostate Cancer
- Other
- Genetic testing
- Neurological disease
- Microbiology
By End User
- Diagnostic Laboratories
- Hospitals & Clinics
- Others
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Molecular Diagnostics Market
5.1. COVID-19 Landscape: Molecular Diagnostics Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Molecular Diagnostics Market, By Product
8.1. Molecular Diagnostics Market, by Product, 2022-2030
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Reagents
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Services & Software
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Molecular Diagnostics Market, By Test Location
9.1. Molecular Diagnostics Market, by Test Location, 2022-2030
9.1.1. Central laboratories
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Point of care
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Over the counter or self-test kits
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Molecular Diagnostics Market, By Technology
10.1. Molecular Diagnostics Market, by Technology, 2022-2030
10.1.1. Polymerase Chain Reaction (PCR)
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. DNA Sequencing & Next- generation Sequencing (NGS)
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. In Situ Hybridization (ISH)
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. DNA Microarrays
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Molecular Diagnostics Market, By Application
11.1. Molecular Diagnostics Market, by Application, 2022-2030
11.1.1. Infectious diseases
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Oncology
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Genetic testing
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Neurological disease
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Microbiology
11.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Molecular Diagnostics Market, By End User
12.1. Molecular Diagnostics Market, by End User, 2022-2030
12.1.1. Diagnostic Laboratories
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Hospitals & Clinics
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Others
12.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Molecular Diagnostics Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.1.3. Market Revenue and Forecast, by Technology (2017-2030)
13.1.4. Market Revenue and Forecast, by Application (2017-2030)
13.1.5. Market Revenue and Forecast, by End User (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Technology (2017-2030)
13.1.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.1.6.5. Market Revenue and Forecast, by End User (2017-2030)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.7.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.1.7.3. Market Revenue and Forecast, by Technology (2017-2030)
13.1.7.4. Market Revenue and Forecast, by Application (2017-2030)
13.1.7.5. Market Revenue and Forecast, by End User (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.2.3. Market Revenue and Forecast, by Technology (2017-2030)
13.2.4. Market Revenue and Forecast, by Application (2017-2030)
13.2.5. Market Revenue and Forecast, by End User (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Technology (2017-2030)
13.2.7. Market Revenue and Forecast, by Application (2017-2030)
13.2.8. Market Revenue and Forecast, by End User (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Technology (2017-2030)
13.2.10. Market Revenue and Forecast, by Application (2017-2030)
13.2.11. Market Revenue and Forecast, by End User (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.2.12.3. Market Revenue and Forecast, by Technology (2017-2030)
13.2.12.4. Market Revenue and Forecast, by Application (2017-2030)
13.2.13. Market Revenue and Forecast, by End User (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.14.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Technology (2017-2030)
13.2.14.4. Market Revenue and Forecast, by Application (2017-2030)
13.2.15. Market Revenue and Forecast, by End User (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.3.3. Market Revenue and Forecast, by Technology (2017-2030)
13.3.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Technology (2017-2030)
13.3.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.7. Market Revenue and Forecast, by End User (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Technology (2017-2030)
13.3.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.9. Market Revenue and Forecast, by End User (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Technology (2017-2030)
13.3.10.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.11.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Technology (2017-2030)
13.3.11.4. Market Revenue and Forecast, by Application (2017-2030)
13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.4.3. Market Revenue and Forecast, by Technology (2017-2030)
13.4.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Technology (2017-2030)
13.4.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.7. Market Revenue and Forecast, by End User (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Technology (2017-2030)
13.4.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.9. Market Revenue and Forecast, by End User (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Technology (2017-2030)
13.4.10.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.11.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Technology (2017-2030)
13.4.11.4. Market Revenue and Forecast, by Application (2017-2030)
13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.5.3. Market Revenue and Forecast, by Technology (2017-2030)
13.5.4. Market Revenue and Forecast, by Application (2017-2030)
13.5.5. Market Revenue and Forecast, by End User (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Technology (2017-2030)
13.5.6.4. Market Revenue and Forecast, by Application (2017-2030)
13.5.7. Market Revenue and Forecast, by End User (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Test Location (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Technology (2017-2030)
13.5.8.4. Market Revenue and Forecast, by Application (2017-2030)
13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)
Chapter 14. Company Profiles
14.1. Siemens Healthineers AG (Germany)
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Quidel Corporation (US)
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. F. Hoffmann-La Roche Ltd. (Switzerland)
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Hologic, Inc. (US)
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Thermo Fisher Scientific, Inc. (US)
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Danaher Corporation (US)
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Illumina, Inc. (US)
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Becton, Dickinson and Company (US)
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Grifols, S.A. (Spain)
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. PerkinElmer, Inc. (US)
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2257
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
